Summary of Purpose
The primary objectives of this study is to evaluate the efficacy of HLCM051 on functional outcome in subjects with acute ischemic stroke and to evaluate the safety of HLCM051 in subjects with acute ischemic stroke.Read More →
The following dates are available for this trial. Trial information last updated on 26 November 2017.
|15 Nov 2017||7 Nov 2016||1 Mar 2018||1 Mar 2018||1 Nov 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Kiyohiro Houkin, MD
email@example.com 81 011 706 5600